Clinical trials
Phase 4 Carcinoma, Non-Small-Cell Lung trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Simcere Pharmaceutical Co., Ltd | 3 |
| Betta Pharmaceuticals Co., Ltd. | 2 |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | 1 |
| Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Henan Cancer Hospital | 1 |
| Jiangsu Famous Medical Technology Co., Ltd. | 1 |
| Nanjing NingQi Medicine Science and Technology Co., Ltd. | 1 |
| Qilu Hospital of Shandong University | 1 |
| Shandong Cancer Hospital and Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 16 |
| Adenocarcinoma | 1 |
| Carcinoma | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.